Abstract:Abstract Background: In the US, gastric cancer (GC) often presents at an advanced stage and is relatively more common in male than female populations. Racial/ethnic minoritized communities bear a heavy burden of overall cancer mortality. Limited research has investigated cause-specific survival and none have evaluated this in GC patients by sex and race/ethnicity. The current study examined racial/ethnic differences in GC-specific survival among GC patients stratified by sex. Methods: We extracted data from GC patients aged 18-64 years in the 2007-2016 Surveillance Epidemiology and End Results (SEER) program. The survival event was measured as GC-specific death or censored at the time of death from other causes or at the last known follow-up. Sex at birth was categorized as “female/male.” Race/ethnicity groups included Asian or Pacific Islander (API), American Indian or Alaska Native (AIAN), Black, Hispanic, and White. Median GC-specific survival time (in months) was estimated using Kaplan-Meier, with comparisons using log-rank tests. Due to the effect modification of the association between race/ethnicity and GC-specific survival by sex (p<0.001), we performed stratified Cox regression assessing racial/ethnic differences in GC-specific survival, adjusting for clinicodemographic characteristics. Results: Of 5,529 GC patients, the mean age was 54.6 years (SD=8.1); 73.7% were male; most (54.2%) were White, followed by 19.4% Hispanic, 14.0% Black, 11.3% API, and 1.2% AIAN. The median GC-specific survival time was 27.0 months for White, 23.0 months for Black, 22.0 months for API, 14.0 months for AIAN, and 12.0 months for Hispanic female patients (p<0.001). The median GC-specific survival time was 23.0 months for API, 20.0 months for White, 18.0 months for Hispanic, 15.0 months for Black, and 12.0 months for AIAN male patients (p=0.006). In the stratified analysis, API (adjusted hazard ratio [aHR]=0.72, 95% CI: 0.55-0.93), White (aHR=0.68, 95% CI: 0.56-0.83), or Black (aHR=0.66, 95% CI: 0.51-0.85) female patients had a lower risk of death than Hispanic female patients; no differential GC-specific survival was observed between AIAN and Hispanic female patients (aHR=1.22, 95% CI: 0.57-2.59). However, White male patients had a greater risk of death than their Hispanic counterparts (aHR=1.18, 95% CI: 1.04-1.34); no differential GC-specific survival between AIAN (aHR=1.34, 95% CI: 0.88-2.04), Black (aHR=1.18, 95% CI: 1.00-1.39), or API (aHR=1.05, 95% CI: 0.88-1.26) and Hispanic male patients was observed. Conclusions: In this population-based sample, racial/ethnic differences in GC-specific survival among GC patients were modified by sex. The relationship between sex and race/ethnicity in GC-specific survival is nuanced. White men and Hispanic women have the highest burden of GC, and men have lower survival than women. These findings suggest the potential need for tailored interventions to improve survival outcomes across racial/ethnic patient populations. Citation Format: Jincong Q. Freeman, Ted O. Akhiwu, Joseph O. Atarere, Adam W. Scott. Racial and ethnic differences in cause-specific survival among gastric cancer patients and effect modification by sex: A US population-based study [abstract]. In: Proceedings of the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2023 Sep 29-Oct 2;Orlando, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(12 Suppl):Abstract nr C081.

Demographic comparison of the burden of endoscopically screenable cancers in the United States.

Population-Based Analysis of Differences in Gastric Cancer Incidence Among Races and Ethnicities in Individuals Age 50 Years and Older

Racial, Ethnic, and Sex Differences in Incidence-Based Mortality of Aggregate Upper Gastrointestinal Cancers.

Racial disparities of gastric cancer in the USA: an overview of epidemiology, global screening guidelines, and targeted screening in a heterogeneous population

One Size Does Not Fit All: Marked Heterogeneity in Incidence of and Survival from Gastric Cancer among Asian American Subgroups

Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time

A bird's-eye view of disparity from public historic cancer mortality data in the US: Advocacy for gastrointestinal cancers and for inter-agency data harmonization.

Differential burdens: A study of gastric cancer hospitalization and outcomes across race and ethnicities.

Abstract C081: Racial and ethnic differences in cause-specific survival among gastric cancer patients and effect modification by sex: A US population-based study

Abstract 4871: Colorectal cancer incidence and overall survival by race, stage, and age: A SEER database analysis, 2009-2020

Race/Ethnicity-, Socioeconomic Status-, and Anatomic Subsite-Specific Risks for Gastric Cancer

Disparities in prevalence, location, and shape characteristics of colorectal neoplasia between South Korean and U.S. patients

Gastric cancer incidence, mortality and burden in adolescents and young adults: a time-trend analysis and comparison among China, South Korea, Japan and the USA

Determinants of Cancer Screening Disparities Among Asian Americans: A Systematic Review of Public Health Surveys

Disparities in Colorectal Cancer Incidence among Asian and Pacific Islander Populations in Guam, Hawai'i, and the United States

Abstract C119: Rising incidence and racial disparities of early-onset endometrial cancer in the United States, 1995-2018

Patient‐ and system‐level factors associated with racial/ethnic disparities in the delivery of guideline‐concordant therapy among US patients with gastric cancer

Trends in Esophageal Cancer Mortality and Stage at Diagnosis by Race and Ethnicity in the United States

Significant Racial Disparities Exist in Noncardia Gastric Cancer Outcomes Among Kaiser Permanente's Patient Population

Colorectal Neoplasia in Asian Americans Undergoing First Time Asymptomatic Average-risk Screening Colonoscopies

Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America